Research at Georgetown Lombardi
The mission of the Georgetown Lombardi Comprehensive Cancer Center (Lombardi) is to provide expert and humanitarian care to cancer patients, their families, and those at risk, and to bring an increased understanding of the cellular and molecular biology of the malignant process and the individual's and society's response to it. LCCC members, under support form the National Institutes of Health Cancer Center Support Grant (CCSG), and many other federal government, foundation, corporate, and private grants are critical to the mission.
Lombardi and MedStar, a Working Partnership
Since the establishment of the Lombardi Comprehensive Cancer Center in 1970, Georgetown University (GU) has maintained a high level of commitment to the success of the Cancer Center. With CCSG support and guided by its external and internal advisory committees, the Lombardi has developed and maintained an outstanding interdisciplinary team of basic, population-based, and clinical researchers who are committed to high quality and clinically relevant cancer research. The success of Lombardi's research environment is demonstrated in its three basic science programs, two clinical translational programs, and two population-based prevention and control programs. Currently, Lombardi is represented by approximately 116 full Members (full time, established cancer researchers), participating in 7 specific research programs with 11 shared resources, working primarily on the GU campus.
In 2000, GU Hospital became a part of MedStar Health, a non-profit network of seven regional hospitals, which together see more than 7,000 new cancer patients annually. This affiliation has significantly strengthened both clinical activity and clinical research at Lombardi.
Accordingly, Lombardi is interested in expanding its range of research programs and membership. Specifically, Lombardi is now reaching out to all faculty who are only beginning to develop their cancer research programs and to clinical faculty who would like to make the commitment to enroll patients on GU/MedStar Health cancer clinical trials.
To accomplish this transition, Lombardi has recently added a new category of membership, the Associate Member, to promote collaborations and clinical trials accrual by faculty throughout the MedStar hospital system. Accordingly, Associate Membership is now available to interested GU/MedStar faculty, throughout the entire MedStar Network.
Working together, Members and Associate Members of Lombardi will carry out the vital missions of our Cancer Center.